GE Healthcare to Acquire Diagnostics Company Clarient
General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.
Featured Articles
Neurotez Developing Hormone Replacement Therapy for Alzheimer’s
Could the same hormone that regulates your appetite keep you from developing Alzheimer’s?
Cardiogenesis Breaks Ground on Heart-Pumping New Research
Cardiogenesis, the clinical and market leader in transmyocardial revascularization (TMR), revealed this week that it has enrolled its first two patients for its feasibility study involving the cutting-edge PHOENIX System.
Ischemic Stroke: Challenging Market, Huge Need
Time is critical when a patient suffers from a stroke.
NeoVista’s Macular Degeneration Device Improves Visual Acuity in Yearlong Study
Medical device company NeoVista, Inc., recently announced 12-month results from its MERITAGE study in patients with wet age-related macular degeneration, a leading cause of vision loss in older Americans.
OneMedPlace Announces “OneMedForum 2011” Finance Conference for Emerging Healthcare and Life Science Companies
OneMedPlace announced today that its “OneMedForum 2011” business development and finance conference for emerging healthcare and life science companies will be held January 11-13, 2011, in San Francisco at the Sir Francis Drake Hotel.
Companies Presenting at Advamed2010
More than 50 innovative medical technology companies from around the world will present their company profiles to potential investors, partners and industry stakeholders at AdvaMed 2010: The MedTech Conference, being held October 18-20, 2010 in Washington, D.C.
Genomics Researchers Have a Bone to Pick with Multiple Myeloma
Signal Genetics, a predictive genetic testing company focused on oncology, recently announced that it would work with pharmaceutical company Array BioPharma to advance both companies’ goals of finding biomarkers for myeloma patients.
Giving Peyronie’s Patients More Treatment Options
An disorder frequently associated with ED is Peyronie’s disease.
Urovalve Bladder Management System Shows Early Promise in Clinical Trial
Urovalve announced promising early results this week in a multi-site clinical trial of its Surinate Bladder Management System.